Key result
Mesenteric fat thickness significantly correlated with serum concentrations of apolipoprotein A-II (r=0.5, p<0.01) and apolipoprotein B (r=0.47, p<0.01) in patients with peripheral arterial disease.
Why the study?
Does mesenteric fat thickness correlate with serum apolipoprotein levels in patients with peripheral arterial occlusive disease?
Cross-Sectional (n=35)
No
Does mesenteric fat thickness correlate with serum apolipoprotein levels in patients with peripheral arterial occlusive disease?
Effect estimate: r = 0.5 for apoAII; r = 0.47 for apoB
p-value: p=<0.01
Mesenteric fat thickness correlates significantly with atherogenic apoB and apoAII levels in patients with peripheral arterial disease, highlighting visceral fat as a marker of atherosclerotic risk.
Visceral fat assessment may refine PAD risk evaluation; observational data leave causal and prognostic value open.
BACKGROUND: Visceral fat possesses the most detrimental potential for cardiovascular morbidity through the release of adipokines, as well as metabolic and proinflammatory mediators, which adversely affect metabolic and vascular homeostasis. Among the different types of visceral adipose tissue, mesenteric fat is considered particularly detrimental, due to its close proximity to the portal circulation, affecting directly the liver, which is the main regulator of body metabolic homeostasis. Mesenteric fat can be reliably estimated using abdominal ultrasonography, the only available imaging method able to depict individual mesenteric leaves. Aim of the present study was to investigate the correlation of mesenteric fat thickness (MFT) with serum apolipoprotein levels in patients undergoing digital subtraction angiography in a single center. METHODS: 35 male patients with peripheral arterial disease were examined. After careful examination of the periumbilical area, the mesenteric leaves were identified. The maximal distance between each pair of sequential leaves was measured, and the mean value of the three thickest leaves was determined as the mesenteric fat thickness. Six apolipoprotein fasting serum concentrations were measured using a Luminex proteomics platform (xMAP Multiplex immunoassay): apolipoprotein A-I (apoAI), apolipoprotein A-II (apoAII), apolipoprotein B (apoB), apolipoprotein C-II (apoCII), apolipoprotein C-III (apoCIII) and apolipoprotein E (apoE). RESULTS: MFT correlated with apoAII and apoB serum concentrations. The correlations with apoAII and apoB remained significant following correction for BMI. No correlations were noted between MFT and serum apoAI, apoCII, apoCIII or apoE levels before or after adjustment for BMI. CONCLUSIONS: Our study indicates that MFT is significantly correlated with the concentration of atherogenic low density lipoproteins particles, as well as with apoAII, a determinant of free fatty acids levels. No correlation was observed between mesenteric fat thickness and very low density lipoprotein or chylomicron particles concentration.
No takes yet. Share an insight, caveat, or question.
Perelas et al. (2012) conducted a cross-sectional in Peripheral arterial occlusive disease (n=35). Mesenteric fat thickness was evaluated on Correlation between mesenteric fat thickness and serum apolipoproteins (r = 0.5 for apoAII; r = 0.47 for apoB, p=<0.01). Mesenteric fat thickness significantly correlated with serum concentrations of apolipoprotein A-II (r=0.5, p<0.01) and apolipoprotein B (r=0.47, p<0.01) in patients with peripheral arterial disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: